➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Express Scripts
Colorcon
Mallinckrodt
Moodys

Last Updated: October 25, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR AMMONUL

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for AMMONUL

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00597909 ↗ Efficacy and Safety Study of Ammonul┬« in Patients With Grade 3 or 4 Hepatic Encephalopathy Terminated Horizon Pharma Ireland, Ltd., Dublin Ireland Phase 2 2007-12-01 The primary purpose of this study is to evaluate the safety and effectiveness of Ammonul┬« in subjects who become hospitalized with Grade 3 or 4 hepatic encephalopathy (HE).
NCT00977600 ↗ A Study of Glyceryl Tri-(4-phenylbutyrate) (GT4P) Completed Ucyclyd Pharma, Inc. Phase 1 2005-03-01 To determine the safety and tolerability of single oral doses of HPN-100 as a formulation (GT4P-F) and GT4P as the active pharmaceutical ingredient (GT4P-API) administered to healthy male subjects.
NCT00977600 ↗ A Study of Glyceryl Tri-(4-phenylbutyrate) (GT4P) Completed Horizon Pharma Ireland, Ltd., Dublin Ireland Phase 1 2005-03-01 To determine the safety and tolerability of single oral doses of HPN-100 as a formulation (GT4P-F) and GT4P as the active pharmaceutical ingredient (GT4P-API) administered to healthy male subjects.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for AMMONUL

Condition Name

Condition Name for AMMONUL
Intervention Trials
Hepatic Encephalopathy 1
Healthy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for AMMONUL
Intervention Trials
Hepatic Encephalopathy 1
Brain Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for AMMONUL

Trials by Country

Trials by Country for AMMONUL
Location Trials
United States 2
Ukraine 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for AMMONUL
Location Trials
Texas 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for AMMONUL

Clinical Trial Phase

Clinical Trial Phase for AMMONUL
Clinical Trial Phase Trials
Phase 2 1
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for AMMONUL
Clinical Trial Phase Trials
Terminated 1
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for AMMONUL

Sponsor Name

Sponsor Name for AMMONUL
Sponsor Trials
Horizon Pharma Ireland, Ltd., Dublin Ireland 2
Ucyclyd Pharma, Inc. 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for AMMONUL
Sponsor Trials
Industry 2
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Mallinckrodt
Colorcon
Moodys
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.